首页> 外国专利> TMEM100 A pharmaceutical composition for preventing or treating blood dyscrasia comprising TMEM100 protein

TMEM100 A pharmaceutical composition for preventing or treating blood dyscrasia comprising TMEM100 protein

机译:TMEM100用于预防或治疗血液异常的药物组合物,其包含TMEM100蛋白

摘要

The present invention relates to a pharmaceutical composition for preventing or treating TMEM100 protein-containing hematopoietic disorders, and more particularly, to a pharmaceutical composition for preventing or treating hematopoietic disorders comprising a TMEM100 protein or a polynucleotide encoding the same, A method for preventing or treating hematopoietic disorders, a food composition for improving hematopoietic disorders comprising a TMEM100 protein or a polynucleotide encoding the same, and a feed composition.The TMEM100 protein of the present invention promotes the proliferation or differentiation of hematopoietic stem cells, promotes the development of red blood cells or lymphocyte cells, and helps the development of the liver, spleen or bone marrow, which controls the hematopoiesis, so that the hematopoietic process normally occurs. Therefore, the TMEM100 protein can be usefully used as a therapeutic agent for hematopoietic disorders related diseases.
机译:本发明涉及用于预防或治疗含TMEM100蛋白的造血疾病的药物组合物,更具体地说,涉及一种用于预防或治疗包含TMEM100蛋白或编码该TMEM100蛋白的多核苷酸的药物组合物,预防或治疗方法。造血功能障碍,用于改善造血功能障碍的食品组合物,其包含TMEM100蛋白或编码该TMEM100蛋白的多核苷酸,以及饲料组合物。本发明的TMEM100蛋白促进造血干细胞的增殖或分化,促进红细胞的发育。或淋巴细胞,并有助于控制造血功能的肝脏,脾脏或骨髓的发育,因此造血过程通常会发生。因此,TMEM100蛋白可以有效地用作与造血疾病有关的疾病的治疗剂。

著录项

  • 公开/公告号KR101805771B1

    专利类型

  • 公开/公告日2017-12-08

    原文格式PDF

  • 申请/专利权人 가천대학교 산학협력단;

    申请/专利号KR20150164822

  • 发明设计人 이영재;문은혜;

    申请日2015-11-24

  • 分类号A61K38/16;A23K1/16;A23L1/305;A61K48;

  • 国家 KR

  • 入库时间 2022-08-21 12:41:30

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号